EVERY PATIENT MATTERS
At Essential Pharma, we believe that every patient should have access to the medicines they need. We work smarter to develop and deliver medicines for patients in small, underserved or rare disease populations who might otherwise be overlooked.






INNOVATION THAT MATTERS

From manufacturing therapies otherwise at risk of discontinuation, to developing treatments for patient groups with few to no alternatives, we apply our expertise and find creative ways to deliver reliable, high-quality medicines that can transform lives.

THERAPEUTIC AREAS
With a growing portfolio of high-quality products reaching patients in approximately 70 countries, our medicines cover a range of therapeutic areas with a particular focus on rare disease, CNS, ophthalmology and gastroenterology – where specialised expertise makes a critical difference.


CNS


Gastroenterology


Ophthalmology


Cardiovascular


Dermatology


Endocrinology


Gynaecology


Infectious Diseases


Rare disease


Rheumatology


OUR DEVELOPMENT PIPELINE
Our first development-stage asset is an anti-GD2 antibody in clinical development for the treatment of high-risk neuroblastoma, which represents 7-10% of all childhood cancers. We are committed to growing our pipeline further, with therapeutic options for patients in areas of significant unmet need.

JOIN THE TEAM
At Essential Pharma we challenge convention and delve deeper to ensure patients have access to the high-quality medicines they need.
We are open to applications from driven and passionate individuals from all backgrounds who share our commitment to making a difference for patients in niche populations. If you are eager to transform lives while advancing your career in a meaningful way, we want to connect with you.

